Tiny tablet, big hope: new PKU supplement put to the test
NCT ID NCT06694662
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a new microtablet supplement called PKU EASY Microtabs Plus in 10 people with PKU aged 3 and older. The supplement is a slow-release protein substitute designed to help manage PKU. Over one week, researchers checked how well participants tolerated it (stomach issues), how much they actually took, and whether they liked the taste and texture. It's a small, early-stage study focused on acceptability, not on long-term disease control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PKU EASY Microtabs Plus (a slow-release, phenylalanine-free protein substitute with amino acids, vitamins, and minerals)
What this could lead to
If successful, this could provide a more convenient and tolerable dietary supplement option for people with PKU.
What could go wrong
This is a very small, short-term study (10 participants, 1 week) focused only on acceptability and tolerance, not on long-term health outcomes. Results may not apply to all PKU patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA (PKU) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Birmingham Children's Hospital
Birmingham, UK, B4 6NH, United Kingdom